Cargando…

Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study

Within the human intestinal tract, dietary, microbial- and host-derived compounds are used as signals by many pathogenic organisms, including Clostridioides difficile. Trehalose has been reported to enhance virulence of certain C. difficile ribotypes; however, such variants are widespread and not co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, Anthony M., Moura, Ines B., Arai, Norie, Spittal, William, Clark, Emma, Nishida, Yoshihiro, Harris, Hannah C., Bentley, Karen, Davis, Georgina, Wang, Dapeng, Mitra, Suparna, Higashiyama, Takanobu, Wilcox, Mark H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284250/ https://www.ncbi.nlm.nih.gov/pubmed/34277467 http://dx.doi.org/10.3389/fcimb.2021.670935

Ejemplares similares

2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
por: Wiese, Maria, et al.
Publicado: (2022)

The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection
por: Buckley, Anthony M, et al.
Publicado: (2021)

Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile
por: Yang, Jingpeng, et al.
Publicado: (2019)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

An Atypical Case of Monomicrobial Clostridioides difficile Septicemia With No Gastrointestinal Manifestations
por: Wang, Liqian, et al.
Publicado: (2022)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
por: Gu, Ting, et al.
Publicado: (2022)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Gut Microbiota Diversity of Preterm Neonates Is Associated With Clostridioides Difficile Colonization
por: Couturier, Jeanne, et al.
Publicado: (2022)

The impact of dietary fibers on Clostridioides difficile infection in a mouse model
por: Wu, Zhengjie, et al.
Publicado: (2022)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Clostridioides difficile
por: Seth-Smith, Helena M. B., et al.
Publicado: (2021)

S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Clostridioides difficile Infection by Modulating Inflammatory Response
por: Costa, Deiziane V. S., et al.
Publicado: (2021)

High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2021)

Application of a core genome sequence typing (cgMLST) pipeline for surveillance of Clostridioides difficile in China
por: Wang, Yuan Yuan, et al.
Publicado: (2023)

Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
por: Kulecka, Maria, et al.
Publicado: (2023)

Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
por: Normington, Charmaine, et al.
Publicado: (2021)

High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With Clostridioides Difficile Infection
por: Lee, Sang Hoon, et al.
Publicado: (2022)

Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage
por: Harrison, Mark A., et al.
Publicado: (2021)

Comparative biofilm-forming ability between Clostridioides difficile strains isolated in Latin America and the epidemic NAP1/027 strain
por: Morais, Maria Luana Gaudencio dos Santos, et al.
Publicado: (2022)

Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of Clostridioides difficile Toxin A and Serves as an Internalizing Receptor
por: Schöttelndreier, Dennis, et al.
Publicado: (2020)

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China
por: Chen, Yunbo, et al.
Publicado: (2022)

Leptin Receptor q223r Polymorphism Influences Clostridioides difficile Infection-Induced Neutrophil CXCR2 Expression in an Interleukin-1β Dependent Manner
por: Horrigan, Olivia, et al.
Publicado: (2021)

Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates
por: Pensinger, Daniel A., et al.
Publicado: (2023)

Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer
por: Varga, Adorján, et al.
Publicado: (2023)

Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting
por: Azzini, Anna Maria, et al.
Publicado: (2023)

In vitro models to study Clostridioides difficile infection: current systems and future advances
por: Ewin, Duncan, et al.
Publicado: (2023)

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020)

Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection
por: Murayama, Asako, et al.
Publicado: (2022)

Gut Microbiota Composition Associated With Clostridium difficile-Positive Diarrhea and C. difficile Type in ICU Patients
por: Duan, Juping, et al.
Publicado: (2020)

Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection
por: Madden, Gregory R., et al.
Publicado: (2023)

One size does not fit all – Trehalose metabolism by Clostridioides difficile is variable across the five phylogenetic lineages
por: Marshall, Andrew, et al.
Publicado: (2023)

Editorial: Clostridium difficile infection in the Asia-Pacific region
por: Jin, Dazhi, et al.
Publicado: (2022)

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
por: Eyre, David W., et al.
Publicado: (2019)

Clostridioides difficile infection: curbing a difficult menace
por: Khanna, Sahil, et al.
Publicado: (2022)

Immune response against Clostridioides difficile and translation to therapy
por: Sehgal, Kanika, et al.
Publicado: (2021)

Epidemiology of community-acquired and recurrent Clostridioides difficile infection
por: Fu, Yichun, et al.
Publicado: (2021)

The interplay of Clostridioides difficile infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021)

The Transcriptional Regulator Lrp Contributes to Toxin Expression, Sporulation, and Swimming Motility in Clostridium difficile
por: Chen, Kuan-Yu, et al.
Publicado: (2019)

Transitions of care in Clostridioides difficile infection: a need of the hour
por: Khanna, Sahil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7a832qpe2vo92g7i2t7jrt4um6